|
Gene: PCNX4 |
Gene summary for PCNX4 |
Gene summary. |
Gene information | Species | Human | Gene symbol | PCNX4 | Gene ID | 64430 |
Gene name | pecanex 4 | |
Gene Alias | C14orf135 | |
Cytomap | 14q23.1 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q63HM2 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
64430 | PCNX4 | RNA-P17T-P17T-2 | Human | Lung | IAC | 4.30e-05 | 5.08e-01 | 0.3371 |
64430 | PCNX4 | RNA-P17T-P17T-4 | Human | Lung | IAC | 7.92e-03 | 3.25e-01 | 0.343 |
64430 | PCNX4 | RNA-P17T-P17T-8 | Human | Lung | IAC | 1.46e-09 | 6.06e-01 | 0.3329 |
64430 | PCNX4 | RNA-P6T1-P6T1-4 | Human | Lung | MIAC | 3.26e-05 | 7.70e-01 | -0.0263 |
64430 | PCNX4 | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 1.99e-06 | 2.76e-01 | -0.0166 |
64430 | PCNX4 | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 3.12e-08 | 3.17e-01 | -0.0132 |
64430 | PCNX4 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 1.97e-09 | 3.15e-01 | -0.013 |
64430 | PCNX4 | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 2.00e-02 | 2.34e-01 | -0.0121 |
64430 | PCNX4 | RNA-P7T1-P7T1-4 | Human | Lung | AIS | 1.78e-02 | 3.66e-01 | -0.0809 |
64430 | PCNX4 | HTA12-15-2 | Human | Pancreas | PDAC | 7.26e-07 | 6.06e-01 | 0.2315 |
64430 | PCNX4 | HTA12-23-1 | Human | Pancreas | PDAC | 2.07e-02 | 5.65e-01 | 0.3405 |
64430 | PCNX4 | HTA12-26-1 | Human | Pancreas | PDAC | 9.38e-10 | 6.57e-01 | 0.3728 |
64430 | PCNX4 | HTA12-29-1 | Human | Pancreas | PDAC | 4.10e-25 | 6.74e-01 | 0.3722 |
64430 | PCNX4 | male-WTA | Human | Thyroid | PTC | 1.41e-16 | 1.22e-01 | 0.1037 |
64430 | PCNX4 | PTC01 | Human | Thyroid | PTC | 2.67e-08 | 1.11e-01 | 0.1899 |
64430 | PCNX4 | PTC04 | Human | Thyroid | PTC | 3.24e-13 | 2.79e-01 | 0.1927 |
64430 | PCNX4 | PTC05 | Human | Thyroid | PTC | 2.01e-10 | 3.59e-01 | 0.2065 |
64430 | PCNX4 | PTC06 | Human | Thyroid | PTC | 1.72e-13 | 4.01e-01 | 0.2057 |
64430 | PCNX4 | PTC07 | Human | Thyroid | PTC | 3.21e-16 | 3.79e-01 | 0.2044 |
64430 | PCNX4 | ATC09 | Human | Thyroid | ATC | 8.87e-17 | 4.13e-01 | 0.2871 |
Page: 1 2 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PCNX4 | SNV | Missense_Mutation | c.2882N>C | p.Ile961Thr | p.I961T | Q63HM2 | protein_coding | deleterious(0) | benign(0.339) | TCGA-BK-A139-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
PCNX4 | SNV | Missense_Mutation | novel | c.299N>T | p.Thr100Ile | p.T100I | Q63HM2 | protein_coding | deleterious(0.01) | benign(0.101) | TCGA-BK-A13B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
PCNX4 | SNV | Missense_Mutation | novel | c.1622N>C | p.Leu541Ser | p.L541S | Q63HM2 | protein_coding | deleterious(0) | possibly_damaging(0.902) | TCGA-BK-A6W3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PCNX4 | SNV | Missense_Mutation | novel | c.1595N>C | p.Asp532Ala | p.D532A | Q63HM2 | protein_coding | deleterious(0) | probably_damaging(0.914) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PCNX4 | SNV | Missense_Mutation | novel | c.1148N>T | p.Ser383Phe | p.S383F | Q63HM2 | protein_coding | tolerated(0.16) | benign(0.44) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PCNX4 | SNV | Missense_Mutation | novel | c.2450N>A | p.Thr817Asn | p.T817N | Q63HM2 | protein_coding | tolerated(0.17) | benign(0) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PCNX4 | SNV | Missense_Mutation | c.2905N>T | p.Asp969Tyr | p.D969Y | Q63HM2 | protein_coding | deleterious(0.01) | possibly_damaging(0.853) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
PCNX4 | SNV | Missense_Mutation | novel | c.1004N>G | p.Lys335Arg | p.K335R | Q63HM2 | protein_coding | tolerated(0.89) | benign(0) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
PCNX4 | SNV | Missense_Mutation | novel | c.2996N>G | p.Tyr999Cys | p.Y999C | Q63HM2 | protein_coding | deleterious(0) | probably_damaging(0.982) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
PCNX4 | SNV | Missense_Mutation | c.2548N>C | p.Asn850His | p.N850H | Q63HM2 | protein_coding | tolerated(0.53) | benign(0) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |